Stocks and Investing Stocks and Investing
Fri, August 27, 2010
Thu, August 26, 2010
Wed, August 25, 2010
Tue, August 24, 2010
Mon, August 23, 2010

MusclePharm Appoints Mariel Selbovitz, MPH, Director of Global Therapeutics Product Procurement Development


Published on 2010-08-23 05:55:18 - Market Wire
  Print publication without navigation


DENVER--([ BUSINESS WIRE ])--MusclePharm® Corporation (OTCBB:[ MSLP ]), one of the fastest growing nutritional supplement companies in the United States with a proprietary formulation used in eight performance products, today announced the appointment of Mariel Selbovitz, MPH, as Director of Global Therapeutics Product Procurement Development.

"We are thrilled to have Ms. Selbovitz join the MusclePharm team as we enter the therapeutic, nutritional supplementation market that is focused on products to meet the nutritional requirements of people living with HIV/AIDS"

aWe are thrilled to have Ms. Selbovitz join the MusclePharm team as we enter the therapeutic, nutritional supplementation market that is focused on products to meet the nutritional requirements of people living with HIV/AIDS,a stated Cory Gregory, MusclePharma™s President. aMusclePharm is working to greatly expand our sales of therapeutic, nutritional supplementation and provide increased help to people in need across the globe.a

Mr. Gregory continued, aWe believe Ms. Selbovitz expertise and experience in the field of HIV will assist us secure distribution of MusclePharm products, such as Recon, to people living with the HIV disease in developing nations thru The Global Fund to Fight AIDS, Tuberculosis and Malaria, and The Presidents Emergency Plan for AIDS Relief (PEPFAR).a

The Global Fund to Fight AIDS, Tuberculosis and Malaria is an international financing institution that invests the worlda™s money to battle disease. To date, it has committed US$19.3 billion in 144 countries to support large-scale prevention, treatment and care programs against these three diseases.

PEPFAR was launched in 2003 by President George W. Bush, and is the largest effort by any nation to combat a single disease with $18 billion dollars dedicated to fight HIV/AIDS in developing nations over the five year period of 2003-2008. In the first five years of the program, PEPFAR focused on establishing and scaling up prevention, care and treatment programs. It achieved success in expanding access to HIV prevention, care and treatment in low-resource settings.

By securing procurement of the Global Fund and PEPFAR, MusclePharm will be able to distribute Recon and other supplements to millions of people with HIV/AIDS worldwide thru government funds. In July 2010, MusclePharm presented at the 18th International AIDS Conference on the benefits of Recon in people with HIV/AIDS, sponsored by the National Association of People with AIDS (NAPWA) and the AIDS Institute, both leading HIV legislative and advocacy organizations.

aWith Ms. Selbovitz extensive experience and assistance we plan to reach millions of people living with HIV in developing nations,a stated Dr. Roscoe Moore, former United States Surgeon General, and Chief Science Director for MusclePharm. aParticipating in programs such as the Global Fund and PEPFAR and will enable MusclePharm to help counteract some of the devastating effects of HIV related nutritional deficiencies which greatly affect the immune system, as well as the growth and retention of muscle mass.a

Ms. Selbovitz is a graduate of Cornell University and received her Mastera™s in Public Health at the Johns Hopkins University Bloomberg School of Health. She worked as the Client Intake Specialist at Positive Health Project and Syringe Exchange Program Coordinator at the Foundation for Research on Sexually Transmitted Diseases and is a partner in BioEquity Partners.

aI am honored to join MusclePharm in their quest to provide therapeutic, nutritional supplementation to address wasting syndrome in people living with HIV/AIDS,a stated Mariel Selbovitz, MPH. aPeer reviewed publications on micronutrient deficiencies and malnutrition in AIDS patients definitively concur that aggressive clinical intervention is critical for improving morbidity and mortality among this patient population.a

Selbovitz is also a member of the Cornell AIDS Clinical Trials Group Community Advisory Board and AIDS Treatment Advocacy Coalition. She presented at the 5th European Conference on Clinical and Social Research on AIDS and Drugs, International Conference on Antiviral Research, 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention and XVIII International AIDS Conference.

About MusclePharm

MusclePharma™s top management has extensive experience in the sports world and has harnessed this drive and focus into building a business to benefit its customers and help Fuel The Athlete Insidea". Headquartered in Aurora, Colorado, the company is a fast-growing developer and manufacturer of safe, scientifically approved, nutritional supplements that are free of banned substances and tested by athletes. They are designed to help athletes, bodybuilders, weightlifters and fitness enthusiasts improve their performance. Each and every MusclePharm product is the end result of an advanced six-stage research and testing protocol involving the expertise of top nutrition scientists. In addition, the products have been field-tested by more than 100 elite professional athletes from the NFL, MMA, MLB and elsewhere. To date, the company has developed six products: ASSAULT®, BATTLE FUEL®, BULLET PROOF®, COMBAT POWDER®, RECON® and SHRED MATRIX®. Two additional products are due in stores in 2010. MusclePharm products offer up to twice as much of the active ingredients per serving as competing products and incorporate a proprietary mix of ingredients not available elsewhere, such as Suma roota" the aRussian Secret.a Suma is a natural, performance-boosting, strength-and muscle-building herbal derivative that has been used for years by top Russian athletes. For more information, please visit [ www.musclepharm.com ].

Contributing Sources